Fig. 1From: Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targetingPathological Mechanisms induced by Caspase-Cleaved TauBack to article page